These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 855711)
1. Purine toxicity in human lymphoblasts. Snyder FF; Hershfield MS; Seegmiller JE Adv Exp Med Biol; 1977; 76A():30-9. PubMed ID: 855711 [No Abstract] [Full Text] [Related]
2. Purine synthesis and excretion in mutants of the WI-L2 human lymphoblastoid line deficient in adenosine kinase (AK) and adenine phosphoribosyltransferase (APRT). Hershfield MS; Spector EB; Seegmiller JE Adv Exp Med Biol; 1977; 76A():303-13. PubMed ID: 193373 [No Abstract] [Full Text] [Related]
3. Adenine and adenosine are toxic to human lymphoblast mutants defective in purine salvage enzymes. Hershfield MS; Snyder FF; Seegmiller JE Science; 1977 Sep; 197(4310):1284-7. PubMed ID: 197600 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and metabolic effects of adenosine and adenine on human lymphoblasts. Snyder FF; Hershfield MS; Seegmiller JE Cancer Res; 1978 Aug; 38(8):2357-62. PubMed ID: 667833 [TBL] [Abstract][Full Text] [Related]
5. Coordinate regulation of the proximal and distal steps of the pathway of purine synthesis de nono in WI-L2 human lymphoblasts. Hershfield MS; Seegmiller JE Adv Exp Med Biol; 1977; 76A():19-29. PubMed ID: 855704 [No Abstract] [Full Text] [Related]
6. Regulation of de novo purine synthesis in human lymphoblasts. Similar rates of de novo synthesis during growth by normal cells and mutants deficient in hypoxanthine-guanine phosphoribosyltransferase activity. Hershfield MS; Seegmiller JE J Biol Chem; 1977 Sep; 252(17):6002-10. PubMed ID: 893394 [No Abstract] [Full Text] [Related]
7. Purine reutilization and synthesis de novo in APRT deficient long-term lymphocyte lines. Spector EB; Hershfield MS; Seegmiller JE Monogr Hum Genet; 1978; 10():108-11. PubMed ID: 723881 [No Abstract] [Full Text] [Related]
8. Analysis of adenosine-mediated pyrimidine starvation using cultured wild-type and mutant mouse T-lymphoma cells. Gudas LJ; Cohen A; Ullman B; Martin DW Somatic Cell Genet; 1978 Mar; 4(2):201-19. PubMed ID: 307279 [TBL] [Abstract][Full Text] [Related]
9. De novo purine synthesis in cultured human fibroblasts. Gordon RB; Thompson L; Johnson LA; Emmerson BT Adv Exp Med Biol; 1979; 122B():1-6. PubMed ID: 94758 [No Abstract] [Full Text] [Related]
10. S-adenosylhomocysteine toxicity in normal and adenosine kinase-deficient lymphoblasts of human origin. Kredich NM; Hershfield MS Proc Natl Acad Sci U S A; 1979 May; 76(5):2450-4. PubMed ID: 221926 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of lymphoid cell growth by adenine ribonucleotide accumulation. The role of phosphoribosylpyrophosphate-depletion induced pyrimidine starvation. van der Kraan PM; van Zandvoort PM; De Abreu RA; van Baal JM; Bakkeren JA Biochim Biophys Acta; 1987 Feb; 927(2):213-21. PubMed ID: 2434139 [TBL] [Abstract][Full Text] [Related]
12. Purine reutilization and synthesis de novo in long-term human lymphocyte cell lines deficient in adenine phosphoribosyltransferase activity. Spector EB; Hershfield MS; Seegmiller JE Somatic Cell Genet; 1978 May; 4(3):253-64. PubMed ID: 694720 [TBL] [Abstract][Full Text] [Related]
13. Experimental modulation of PRPP availability for ribonucleotide synthesis from hypoxanthine in human skin fibroblast cultures. Holland MJ; Klein NC; Cox RP Exp Cell Res; 1978 Feb; 111(2):237-43. PubMed ID: 627232 [No Abstract] [Full Text] [Related]
14. Regulation of purine de novo synthesis in cultured human fibroblasts: the role of P-ribose-PP. Gordon RB; Thompson L; Johnson LA; Emmerson BT Biochim Biophys Acta; 1979 Mar; 562(1):162-76. PubMed ID: 435498 [TBL] [Abstract][Full Text] [Related]
15. Elucidation of aberrant purine metabolism: application to hypoxanthine-guanine phosphoribosylstransferase- and adenosine kinase-deficient mutants, and IMP dehydrogenase- and adenosine deaminase-inhibited human lymphoblasts. Snyder FF; Trafzer RJ; Hershfield MS; Seegmiller JE Biochim Biophys Acta; 1980 Oct; 609(3):492-501. PubMed ID: 6108130 [TBL] [Abstract][Full Text] [Related]
16. PRPP and purine nucleotide metabolism in human lymphoblasts with both PRPP synthetase superactivity and HGPRT deficiency. Becker MA; Kim M; Husain K Adv Exp Med Biol; 1989; 253B():13-20. PubMed ID: 2481968 [No Abstract] [Full Text] [Related]
17. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity. Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis? Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311 [TBL] [Abstract][Full Text] [Related]
19. EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes. Goday A; Simmonds HA; Webster DR; Morris GS Rev Esp Fisiol; 1985 Mar; 41(1):49-54. PubMed ID: 3923578 [TBL] [Abstract][Full Text] [Related]